CANCER CHEMOTHERAPY AND PHARMACOLOGY
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
CANCER CHEMOTHERAPY AND PHARMACOLOGY
CANCER CHEMOTH PHARM
ISSN / eISSN
0344-5704 / 1432-0843
Aims and Scope
Addressing a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels, Cancer Chemotherapy and Pharmacology is an eminent journal in the field. The primary focus in this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. It is essential reading for pharmacologists and oncologists giving results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy.
Subject Area
PHARMACOLOGY & PHARMACY
ONCOLOGY
CiteScore
6.20
View Trend
CiteScore Ranking
Category | Quartile | Rank |
---|---|---|
Medicine - Pharmacology (medical) | Q1 | #58/260 |
Medicine - Toxicology | Q2 | #37/124 |
Medicine - Oncology | Q2 | #122/366 |
Medicine - Pharmacology | Q2 | #104/301 |
Medicine - Cancer Research | Q2 | #100/214 |
Web of Science Core Collection
Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
---|---|
Indexed | - |
Category (Journal Citation Reports 2023) | Quartile |
---|---|
ONCOLOGY - SCIE | Q3 |
PHARMACOLOGY & PHARMACY - SCIE | Q3 |
H-index
100
Country/Area of Publication
UNITED STATES
Publisher
Springer Berlin Heidelberg
Publication Frequency
Monthly
Year Publication Started
1978
Annual Article Volume
115
Open Access
NO
Contact
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started